AF
PSTX

Allworth Financial’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Allworth Financial’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 2158
2021
Q3 		$1K Hold
100
– – ﹤0.01% 1820
2021
Q2 		$1K Hold
100
– – ﹤0.01% 1513
2021
Q1 		$1K Buy
+100
New +$981 ﹤0.01% 1445

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Allworth Financial's PSTX Position: Q4 2021 in Review

Allworth Financial sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Allworth Financial first reported a position in PSTX in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 66 funds tracked by Wall St. Rank hold PSTX as of Q4 2021.

  • Allworth Financial reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Allworth Financial sold 100 Poseida Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • Allworth Financial first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Allworth Financial's Poseida Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Allworth Financial's 13F filing for Q4 2021, filed 21 Jan 2022.